• Pharmaceutical Experience

    • Major pharmaceutical company in a California Judicial Council Coordinated Proceeding involving thousands of cases that alleged that Lipitor, a cholesterol-lowering medication, causes diabetes. Obtained the exclusion of plaintiffs' general causation experts under Sargon Enterprises, Inc. v. University of Southern California, 55 Cal. 4th 747 (2012).
    • GlaxoSmithKline LLC in a federal multi-district litigation in the Southern District of Florida involving Zantac, an acid-reducing medication, and product liability claims, class actions, and requests for medical monitoring. Serves as a member of the MDL Court’s Leadership Development Committee.
    • GlaxoSmithKline LLC in a putative, nationwide class action filed in the Northern District of California that involves claims that Chapstick products were misleadingly labeled as “100% Natural” and containing “Naturally Sourced Ingredients.”  
    • Purdue Pharma LP in a nationwide litigation involving opioid medications in lawsuits filed by State Attorneys Generals, cities, counties, private entities, and individuals that alleged false and misleading marketing, fraud, violations of consumer protection statutes, negligence, and public nuisance.
    • Pfizer in a federal multi-district litigation in the Eastern District of New Orleans involving product liability claims and the chemotherapy treatment, docetaxel.
    • Major pharmaceutical company in the Southern District of New York in product liability cases involving claims that maternal use of an antidepressant during pregnancy causes autism in children.
    • Pfizer in an appeal in the U.S. Court of Appeals for the Fourth Circuit involving thousands of cases that alleged that Lipitor, a cholesterol-lowering medication, causes diabetes. Obtained the affirmance of the exclusion of plaintiffs' general causation experts under Daubert and summary judgment for the company in all cases. See In re Lipitor (Atorvastatin Calcium) Mktg., Sales Practices & Prod. Liab. Litig. (No II) MDL 2502, 892 F.3d 624, 631 (4th Cir. 2018).
    • Pfizer in federal multi-district litigation in the Eastern District of Pennsylvania involving claims that maternal use of an antidepressant, Zoloft, during pregnancy causes birth defects. Obtained the exclusion of plaintiffs' general causation of experts under Daubert and summary judgment summary judgment for the company in all cases, and also secured the affirmance of these decisions in the U.S. Court of Appeals for the Third Circuit. In re Zoloft (Sertraline Hydrochloride) Prod. Liab. Litig., 858 F.3d 787 (3d Cir. 2017); In re Zoloft (Sertraline Hydrochloride) Prod. Liab. Litig., 2015 WL 7776911 (E.D. Pa. 2015); In re Zoloft (Sertraline Hydrochloride) Prod. Liab. Litig., 26 F. Supp. 3d 449 (E.D. Pa. 2014).

    High-Tech Experience

    • High technology company in a putative, nationwide class action filed in the Northern District of California that involved consumer electronics and claims of misleading marketing and for medical monitoring. Obtained summary judgment on all claims based on federal preemption.
    • High technology company in putative, nationwide class actions filed in the Northern and Central Districts of California that involving claims that an app disclosed consumers’ private data, in breach of contract and in violation of various privacy laws.
    Other Products Liability Experience
    • Manufacturing company in a federal multi-district litigation in the Northern District of Florida involving ear plugs and product liability claims brought by military service members.
    • Intuitive Surgical, Inc. at trial in Washington Superior Court involving the da Vinci, a robotic surgical device.  This was the first products liability trial in the country involving the da Vinci.

    Includes matters handled at Dechert or prior to joining the firm.

    • University of California, Berkeley, B.A., 2004, with Distinction
    • Duke University School of Law, J.D., 2009
    • California
    • New York
    • Supreme Court of the United States
    • United States Court of Appeals for the Ninth Circuit
    • United States Court of Appeals for the Second Circuit
    • United States District Court for the Northern District of California
    • United States District Court for the Central District of California
    • United States District Court for the Eastern District of California
    • United States District Court for the Southern District of California
    • United States District Court for the Southern District of New York
    • United States District Court for the Eastern District of New York
    • ABA’s Current Issues in Pharmaceutical and Medical Device Litigation Conference, Panel on “Hot Topics in Products Liability Litigation” (Nov. 14, 2013).
    • Knowledge Group’s Product Liability: Practical Tips and Strategies in Handling Multiple Fronts of Litigation (Apr. 30, 2020).